May 10, 2007
The FDA announced this afternoon a settlement whereby Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin – … Continue reading →
Yesterday the Senate overwhelmingly voted on an FDA Reform package (93-1 vote) that is a legislative solution to many of the issues that have heavily tarnished the agency’s once gold standard image. The bill is the much awaited "Kennedy-Enzi" bill, … Continue reading →